NLRP3 and cryopyrin-associated periodic syndrome: We have previously reported high circulating levels of ASC aggregates during inflammatory flares in CAPS patients with somatic NLRP3 mutations (6) and describe here studies in our cohort before and during therapy with IL-1 inhibition.